Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
257.76
Oct 29 • 9:55 AM ET Dollar change+4.49 Percentage change(1.77%)
Category
Global or ExUS Equities - Industry Sector
Sponsor
Van Eck Associates Corporation
Fund Family
Index
MVIS US Listed Biotech 25 Index
Index Weighting
Active/Passive
Expense
0.35%
Inverse/Leveraged
IPO
Dec 21, 2011
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Sector/Theme
Region
SMA20
5.76%
SMA50
7.12%
SMA200
24.90%
Return% 1Y
42.93%
Return% 3Y
19.95%
Return% 5Y
5.75%
Return% 10Y
Return% SI
Flows% 1M
1.93%
Flows% 3M
4.47%
Flows% YTD
2.92%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
26
AUM
508.47M
NAV/sh
52W High
254.75 1.18%
52W Low
176.30 46.21%
Volatility
1.74% 1.96%
ATR (14)
4.67
RSI (14)
67.29
Beta
0.71
Rel Volume
1.66
Avg Volume
10.87K
Volume
2,050
Perf Week
3.77%
Perf Month
5.39%
Perf Quarter
25.40%
Perf Half Y
39.10%
Perf YTD
36.19%
Perf Year
45.76%
Perf 3Y
79.09%
Perf 5Y
29.20%
Perf 10Y
147.25%
Prev Close
253.27
Price
257.76
Change %
1.77%
VanEck Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.